PolyU Marshall Research Centre for Medical Microbial Biotechnology
PolyU Marshall Research Centre for Medical Microbial Biotechnology aims to advance the diagnosis and treatment of bacterial infections. The Centre is firmly committed to fostering international collaboration, thereby strengthening the global impact of its work in medical microbiology. It also places a strong emphasis on the development of novel antibiotics to combat the escalating threat of antimicrobial resistance.
Read MoreHide
Research Centre for Carbon-Strategic Catalysis
The establishment of the Research Centre for Carbon-Strategic Catalysis (RC-CSC) aims to supply a platform that can strengthen the research collaborations and efforts in PolyU to achieve more impactful outputs on the advanced catalyst design and synthesis for the sustainable energy development strategies. The Hong Kong government has announced that Hong Kong would strive to achieve carbon neutrality before 2050.
Currently, electricity generation was the largest source of carbon emissions, accounting for about 66% of the total emissions in Hong Kong, followed by transport (about 18%) and waste (about 7%, mainly from landfills). Therefore, it is an extremely challenging target to achieve carbon neutrality before 2050, which requires all the joint efforts and participation from all the universities of Hong Kong to formulate the proactive, forward-looking and targeted strategy and platforms. Read MoreHide
Currently, electricity generation was the largest source of carbon emissions, accounting for about 66% of the total emissions in Hong Kong, followed by transport (about 18%) and waste (about 7%, mainly from landfills). Therefore, it is an extremely challenging target to achieve carbon neutrality before 2050, which requires all the joint efforts and participation from all the universities of Hong Kong to formulate the proactive, forward-looking and targeted strategy and platforms. Read MoreHide
Lo Ka Chung Research Centre for Natural Anti-Cancer Drug Development
The Lo Ka Chung Research Centre for Natural Anti-Cancer Drug Development is established in late 2006. Through out the years the centre has carried out pioneering research in natural anti-cancer drugs, and has contributed directly to the community by promoting educational training. So far, the centre has developed two novel drugs to treat cancer. The second drug (BCA-PEG20), which represents a new paradigm for treating many cancer types, has been awarded the Prize of the State of Geneva and Gold Medal with Jury’s Commendation at the 37th International Exhibition of Inventions, New Techniques and Products of Geneva in 2009. We have formulated the drug with state-of-the-art DNA technology and protein modification and significantly prolonged its half-life for therapeutic use. The use of this new drug will open up many new opportunities for treating different types of cancers.
Read MoreHide
Read MoreHide
Henry Cheng Research Laboratory for Drug Development
Located on the seventh floor of the Lee Shau Kee Building on the PolyU campus, the "Henry Cheng Research Laboratory for Drug Development" has a total floor area of 537 square metres. The Laboratory provides state-of-the-art equipment including flow cytometer, confocal microscopy, thermos fisher scientific system and a high-performance liquid chromatography machine, which serves as a technology platform for an excellent research team of chemistry and biology experts to work together towards the common goal of developing new drugs for the benefit of mankind.
Read MoreHide
Read MoreHide
